NEERVANNAN SESHADRI (Chief Operating Officer) sold 5.5% of their position (4.56K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $387.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2026ACC: 0001827584-26-000013
Officer· Chief Operating Officer
Since Oct 2020
-4.56K
Net shares
Net seller
$387.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.56K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.56K
Price / share
$85.00
Trade value
$387.94K
% of position
5.5%
9/4/2026
83.10K→78.53K
Total
Net shares
−4.56K
Net value
-$387.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/4/2026 | S · Sale | −4.56K | $85.00 | $387.94K | 5.5% | 83.10K | 78.53K |
| Total | −4.56K | -$387.94K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned475.00
Total
475.00 indirect475.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 475.00 | Indirect |
| Total | 475.00 | 475.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported